Chin Augmentation Market Report 2026

The chin augmentation market size has grown strongly in recent years. It will grow from $1.21 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to growing acceptance of cosmetic surgery, increasing disposable income levels, advancements in implant materials, expansion of cosmetic clinics, rising influence of aesthetic awareness.

The chin augmentation market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for non-surgical cosmetic treatments, growing adoption of AI-based facial analysis, expansion of medical tourism, rising preference for personalized aesthetic outcomes, continued innovation in biocompatible materials. Major trends in the forecast period include increasing demand for minimally invasive chin augmentation procedures, rising adoption of customized facial implants, growing use of dermal fillers for non-surgical enhancement, expansion of digital facial imaging and planning tools, enhanced focus on aesthetic personalization.

The increasing number of cosmetic procedures is anticipated to drive the growth of the chin augmentation market in the coming years. Cosmetic procedures are medical treatments performed to enhance appearance, improve aesthetic features, or correct physical imperfections. The rising volume of cosmetic procedures is driven by a growing societal focus on physical appearance and ongoing advancements in medical technology, which have made such procedures safer, more effective, and more accessible. Chin augmentation improves facial balance and profile aesthetics, contributing to its growing popularity as a cosmetic procedure for enhancing overall facial harmony. For instance, in June 2024, according to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, the total number of surgical and non-surgical aesthetic procedures increased by 3.4% in 2023, reaching 34.9 million procedures. This included a 5.5% rise in surgical procedures, with more than 15.8 million surgical procedures performed by plastic surgeons, alongside 19.1 million non-surgical procedures. Therefore, the expanding number of cosmetic procedures is fueling the growth of the chin augmentation market.

Major companies operating in the chin augmentation market are concentrating on the development of technologically advanced aesthetic solutions, such as hyaluronic acid (HA) dermal fillers, to address the growing demand for non-surgical cosmetic enhancements and to offer safer and more effective options for facial contouring. Hyaluronic acid dermal fillers are gel-like substances injected into the skin to restore volume, smooth wrinkles, and enhance facial contours. For instance, in March 2024, AbbVie, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had approved JUVÉDERM VOLUMA injectable gel for deep injection. This product is approved for cheek augmentation to correct age-related volume loss in the mid-face and for chin augmentation to improve the chin profile in adults aged 21 years and older.

In April 2024, Beverly JCG Ltd., a Singapore-based wellness and beauty company, acquired BK Aesthetic Clinic for an undisclosed amount. Through this acquisition, Beverly JCG Ltd. aims to expand its presence in the rapidly growing aesthetics and healthcare markets while leveraging the expertise and reputation of a well-known South Korean cosmetic surgeon to enhance its service offerings and financial performance. BK Aesthetic Clinic is a Singapore-based provider specializing in chin augmentation and other aesthetic services.

Major companies operating in the chin augmentation market are AbbVie Inc., Stryker Corporation, Galderma Filler, Merz Pharma Gmbh and Co. Kgaa, InMode Ltd., KLS Martin Group, OsteoMed, Sientra Inc, GC Aesthetics Limited, Hans Biomed, POLYTECH Health and Aesthetics, Implantech Associates Inc, Sebbin Sas, Teoxane, Solta Medical Inc, Silimed, Lucid Implants, Surgiform Technologies, Facial Plastic Surgery Inc, Eurosurgical Ltd, Cadogan Clinic Ltd.

North America was the largest region in the chin augmentation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chin augmentation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chin augmentation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the chin augmentation market by increasing costs of imported medical-grade implants, dermal fillers, surgical instruments, and imaging systems used in cosmetic procedures. Cosmetic clinics and hospitals in North America and Europe are most affected due to reliance on imported aesthetic materials, while Asia-Pacific faces cost pressures linked to medical tourism supply chains. These tariffs are increasing procedure costs and limiting accessibility for some patients. However, they are also encouraging local production of cosmetic implants, regional supplier development, and innovation in cost-effective aesthetic solutions.

The chin augmentation market research report is one of a series of new reports that provides chin augmentation market statistics, including chin augmentation industry global market size, regional shares, competitors with a chin augmentation market share, detailed chin augmentation market segments, market trends and opportunities, and any further data you may need to thrive in the chin augmentation industry. This chin augmentation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chin augmentation, also referred to as genioplasty or mentoplasty, is a cosmetic procedure performed to improve the shape, size, and projection of the chin. The procedure may involve placing implants or reshaping the existing chin bone to create a more harmonious and balanced facial profile. It is commonly undertaken to enhance facial symmetry and overall aesthetic appearance.

The main procedure types for chin augmentation include surgical and non-surgical approaches. Surgical procedures involve operative techniques used to correct or enhance facial structures. The materials used in chin augmentation include implants, dermal fillers, fat grafting, and others, and these procedures are performed for both female and male patients. Chin augmentation is offered by various end users such as hospitals, cosmetic clinics, ambulatory surgical centers, and other healthcare facilities.

The chin augmentation market consists of revenues earned by entities providing services such as chin surgery, chin augmentation with neck liposuction, chin reduction surgery, and revision chin surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The chin augmentation market also includes sales of surgical instruments and equipment, dermal fillers and injectables, facial implants and augmentation kits, and post-operative care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.